NASP Speciality Pharmacy Podcast

Odcinki

• 
  From Access to Outcomes: The Changing Role of HUBs | NASP Specialty Pharmacy Podcast 07.09.2026 24min

  On this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, sits down with Narlyn Lopes and Megan Winebrenner of CenterWell Specialty Pharmacy to talk about how modern hub models have grown well past basic access support; they're now built to deliver a coordinated, personalized experience across the whole specialty medication journey. The conversation digs into how better technology and closer collaboration are cutting down on delays and administrative burden, so patients can start therapy sooner and stay supported once they're on treatment.  
• 
  Easing Prior Auth Pain Points for Specialty Pharmacies with Develop Health | NASP Specialty Pharmacy Podcast 24.08.2026 22min

  In this episode of the NASP Podcast, host Sheila Arquette, President & CEO of NASP, speaks with Nico Kernick, Head of Growth and Operations at Develop Health. They discuss the ways AI is reducing friction and increasing transparency in the prior authorization process for providers and specialty pharmacies. Nico shares how Develop Health's AI-native workflows now support over 3 million patients, boosting submission and first-pass approval rates while keeping providers in control every step of the way. Listeners can expect to learn how pharmacies can get started overnight, plus a special offer for NASP members.  
• 
  Moving Beyond a Check-the-Box Model: Talking Specialty Pharmacy Accreditation with ACHC| NASP Specialty Pharmacy Podcast 10.08.2026 23min

  In this episode of the NASP Podcast, Sheila Arquette, R.Ph., President & CEO of the National Association of Specialty Pharmacy (NASP), sits down with Dr. Caroline Girardeau, PharmD, MBA, PMP, BCPS, Pharmacy Program Director at the Accreditation Commission for Health Care (ACHC), to explore the evolving specialty pharmacy accreditation landscape. Together, they discuss the scope and value of comprehensive specialty pharmacy accreditation, examining how rigorous accreditation standards help improve patient safety, clinical outcomes, operational excellence, and the overall quality of care. They also highlight how specialty pharmacies can leverage accreditation as more than a requirement for participation in payer or limited distribution networks, using it as a strategic framework to drive continuous quality improvement, strengthen operations, and elevate the patient experience.
• 
  The Role of Specialty Pharmacy in Hidradenitis Suppurativa Care at University of Vermont (UVM) Health| NASP Specialty Pharmacy Podcast 08.07.2026 21min

  In this episode, Sheila Arquette, President & CEO of NASP, speaks with Santana VanDyke, MD, Assistant Professor of Dermatology and Director of the Hidradenitis Suppurativa Clinic at University of Vermont Health, and Ryan Lackey, PharmD, CPPS, Ambulatory Pharmacist Clinician and Co-Director of the clinic. They discuss Hidradenitis Suppurativa (HS), including disease presentation, treatment options, emerging therapies, and research currently underway. The conversation highlights UVM Health’s collaborative care model that brings together dermatology and specialty pharmacy to improve the patient experience and clinical outcomes.  
• 
  Breaking Down the 2026 Consolidated Appropriations Act and Its Impact on Specialty Pharmacy | NASP Specialty Pharmacy Podcast 11.06.2026 51min

  In this episode, Sheila Arquette, President & CEO of NASP, speaks with Jonathan L. Swichar, Duane Morris Pharmacy Litigation Group Chair, and Bradley A. Wasser, Duane Morris Pharmacy Litigation Group Partner. They discuss the 2026 Consolidated Appropriations Act and its landmark PBM reform provisions that impact pharmacy network access and transparency. These expert litigators go into detail about what specialty pharmacies should expect as federal agencies enforce the new law and what opportunities and challenges lie ahead for specialty pharmacies.
• 
  The New PBM Regulatory Landscape: Talking Enforcement Trends, Contracting Strategies, and Future Opportunities for Specialty Pharmacies | NASP Specialty Pharmacy Podcast 09.04.2026 46min

  In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Linda Clark and Brad Gallagher, Co-Leaders of Barclay Damon’s Health Care Controversies and Pharmacy Teams. They explore the rapidly evolving Pharmacy Benefit Manager (PBM) regulatory landscape and its impact on specialty pharmacies, offering key considerations for contracting and strategies to strengthen audit readiness and compliance. Linda and Brad also share practical guidance to help specialty pharmacies increasingly under pressure to manage their risk and position themselves for long-term success.
• 
  From Innovation and Integration to Impact: Advancing Health System Specialty Pharmacy at UC Davis Health | NASP Specialty Pharmacy Podcast 10.02.2026 45min

  In this episode, Sheila Arquette, President & CEO of NASP, speaks with David G. Mitchell, PharmD, MBA, CSP, FCPhA, Assistant Chief Pharmacy Officer of Specialty Pharmacy & Home Delivery and Ruth Chen, PharmD, MHA, Manager of the Specialty Pharmacy Hub at UC Davis Health in Sacramento. They look at how UC Davis Health has built and scaled one of California’s most integrated health-system specialty pharmacy programs. Dr. Mitchell shares how being embedded within clinics, care teams, and the EHR enables specialty pharmacy to deliver differentiated clinical and operational value while navigating payer, policy, and access challenges in a rapidly evolving landscape. Dr. Chen discusses why a focused rare disease strategy is essential for health-system specialty pharmacies. She walks through the challenges that existed prior to implementing a centralized rare disease hub model and how those challenges shaped the development of a coordinated, pharmacy-led approach that supports patients and providers across complex therapies. Together, this conversation highlights how structure, strategy, and leadership enable innovation, workforce growth, and improved patient care.
• 
  The Season to Innovate: Strategic Legal and Regulatory Considerations for Approaching Acquisitions and Vetting AI Vendors | NASP Specialty Pharmacy Podcast 09.01.2026 22min

  In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Simone Colgan Dunlap, National Vice Chair of the Quarles Health and Life Sciences Practice Group, and Amy Cotton Peterson, Partner at Quarles. As more automation solutions become available, its vital specialty pharmacy providers strategically approach acquisition of targets that offer technology and AI assets. This discussion explores effective diligence practices, common pitfalls, and risk mitigation strategies for specialty pharmacies navigating mergers and acquisitions and the rapidly evolving use of artificial intelligence.  
• 
  Navigating Treatment of Dermatologic Inflammatory Conditions with Specialty Drug Therapies, with Vanderbilt Specialty Pharmacy, Vanderbilt Health | NASP Specialty Pharmacy Podcast 21.11.2025 17min

  In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Matthew G. Bowles, PharmD, MBA, CSP, Pharmacy Clinical Team Lead with Vanderbilt Specialty Pharmacy, Vanderbilt Health, and lead author on the study “Getting to specialty treatment in dermatologic inflammatory conditions: Treatment requirements and patient journey,” published February 2025 in the Journal of Managed Care & Specialty Pharmacy. They discuss the reasons for conducting and results of the study, as well as the impacts the study may have on specialty and managed care pharmacy.
• 
  Inside M3P: What Medicare Providers and Patients Need to Know | NASP Specialty Pharmacy Podcast 04.11.2025 43min

  During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Sheri Wallace, Account Representative at AcariaHealth Specialty Pharmacy, and Diane Omdahl, RN, MS, founder of 65 Incorporated, published author and consultant on Medicare, to unpack the complexities of the Medicare Prescription Payment Plan (MPPP). Drawing on decades of patient access experience and the finer points of Medicare, they share insights on how these changes impact patients, providers, and pharmacies alike. Learn the importance of education, transparency, and advocacy in ensuring patients don’t fall through the cracks during these changes. Whether you're a provider, pharma partner, or patient advocate, this episode offers practical guidance and expert perspectives to help you navigate the evolving Medicare landscape.
• 
  Talking Intentional Automation in Specialty Pharmacy Referrals with Tennr | NASP Specialty Pharmacy Podcast 24.09.2025 20min

  In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, sits down with Trey Holterman, CEO and Co-Founder of Tennr, a healthcare referral automation platform. They explore Tennr’s journey from startup to industry leader and how focused technology speeds patient access, with a look towards what the future holds for patient engagement and care personalization.
• 
  Turning Data into Action - Exploring Access Analytics and What’s Next for Specialty Pharmacy with Claritas Rx| NASP Specialty Podcast 08.09.2025 33min

  In this episode of the NASP Podcast, Sheila Arquette, President & CEO of the National Association of Specialty Pharmacy, sits down with Hillary Gretton, Director of Data Strategy at Claritas Rx. Together, they explore today’s challenges in market access and patient journey analytics, and how Access Analytics is helping specialty pharmacies, payers, and partners tackle these barriers. The conversation highlights real-world use cases from Claritas Rx’s recent whitepaper, From Prescription to Abandonment: How 31% of Specialty Medications Go Unfilled Across Therapeutic Areas, showing how better data can drive better outcomes.
• 
  Beyond the Script: How AI Is Personalizing Specialty Pharmacy Engagement| NASP Specialty Pharmacy Podcast 06.08.2025 38min

  This special episode of the NASP podcast features MedAdvisor leaders Megan Butterfield, Vice President of Network Solutions and Vinod Subramanian, Chief Operating and AI Officer in conversation with Shelia Arquette, President & CEO of NASP, as part of a collaborative spotlight for MedAdvisor Solutions' Beyond the Script podcast series. They discuss how AI, when applied thoughtfully, can help us not only meet the demands of patients’ increasingly intricate care journeys, but do so in a way that enhances the human experience, facilitating personalized engagement, real-time education, empathy and trust, while keeping what's special about specialty pharmacy. 
• 
  Rewriting the Rules: What’s Ahead for Non-PBM Affiliated Specialty Pharmacies | NASP Specialty Pharmacy Podcast 17.07.2025 53min

  In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Jonathan L. Swichar, Partner and Chair of the Duane Morris Pharmacy Litigation Group, and Bradley A. Wasser, Partner, Duane Morris, LLP. They discuss the dramatically shifting legal and regulatory landscape facing non-PBM affiliated specialty pharmacies and recent federal efforts that are reshaping the ways specialty pharmacies do business.
• 
  Establishing a “Win-Win” Relationship with Government Agencies and PBMs | NASP Specialty Pharmacy Podcast 01.05.2025 49min

  In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Jeffrey S. Baird, Esq., Chairman of the Health Care Group at Brown & Fortunato, P.C. and Bradley W. Howard, shareholder and director at Brown & Fortunato, P.C. In today’s environment, it is challenging enough to profitably run a specialty pharmacy. The pharmacy needs to avoid the additional challenge of inquiries, audits and investigations by governmental agencies and PBMs. This podcast will discuss the proactive steps the specialty pharmacy can take to lower the risk of inquiries, audits and investigations. This podcast will also set out steps the pharmacy can take to resolve inquiries, audits and investigations before they spin out of control. The podcast will focus on the following:• Corporate Compliance Program – The specialty pharmacy needs to implement a robust compliance program that is specific to the pharmacy’s business model. Such a program will head off many problems before they arise…and a compliance program will resolve problems, once arisen, before they spin out of control.• PBMs – A PBM is in a stronger negotiating position than that of the specialty pharmacy. At the end of the day, the PBM “possesses the pharmacy’s money.” This podcast will discuss the steps the pharmacy should take to establish a “win-win” relationship with a PBM. Doing so will eliminate uncertainty and prevent many problems from arising. However, if the PBM ends up bringing an inquiry, audit or investigation against the pharmacy, the podcast will set out the steps the pharmacy should take to resolve the inquiry, audit or investigation without it devolving into an adversarial action.• Governmental Agencies – There are a number of federal and state governmental agencies that a specialty pharmacy may have to deal with. These include (i) the Department of Justice, (ii) the Office of Inspector General, (iii) the DEA, (iv) the FDA, (v) state Attorneys General, and (vi) State Boards of Pharmacy. This podcast will discuss the steps the pharmacy should take when it is investigated by a governmental agency. As with working with PBMs, the pharmacy should strive to resolve a government investigation before it spins out of control. 
• 
  Collaborating with Maxor to Empower Specialty Pharmacy Patients and Providers | NASP Specialty Pharmacy Podcast 07.04.2025 28min

  In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Jessie Heaton, PharmD, MBA, CSP, Vice President of Specialty and Infusion at Maxor, and Michelle Mulgrew, PharmD, Vice President of Commercial Specialty Market Development at Maxor, about specialty pharmacy’s role in rare disease patient care management and how to empower patients, prescribers, and manufacturers to navigate complex clinical needs.  
• 
  Spend More Time Caring for Patients: Talking Technology to Drive Efficiencies with D2 Solutions | NASP Specialty Pharmacy Podcast 05.03.2025 30min

  In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Dean Erhardt, President & CEO of D2 Solutions. They discuss how specialty pharmacies can leverage technology and data analytics to navigate complex accreditation demands and automate high volume low value activity workflows so the expert clinicians can do what they do best - care for patients.
• 
  Into the Volcano: AI and Data Privacy within the Specialty Pharmacy Space | NASP Specialty Pharmacy Podcast 04.02.2025 41min

  In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Simone Colgan Dunlap, National Vice Chair of the Quarles' Health & Life Sciences Practice Group and Candace Lerman, JD, at Rare Candace. They discuss the current impacts of AI on the healthcare space and how those within specialty pharmacy may implement AI in ways that prevent detrimental outcomes, stay compliant with evolving regulations, avoid legal pitfalls, and ultimately benefit patients.
• 
  Talking Integration to Build Healthier Communities and Specialty Pharmacies with PrimeRx | NASP Specialty Pharmacy Podcast 14.01.2025 31min

  During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Ketan Mehta, the visionary CEO of PrimeRx. They explore how the advancement of technology has changed the landscape of specialty pharmacy and ways digital integration can help specialty pharmacies achieve a patient-centric holistic ecosystem.
• 
  Navigating the Digital Era and Beyond for Engaging Key Decision Makers in Specialty Pharmacy | NASP Specialty Pharmacy Podcast 18.12.2024 44min

  In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Bridgette Kanz Schroader, PharmD, MPA, BCOP, Associate Director within the Medical Affairs Strategy & Publications team at Market Access & Healthcare Consulting, part of Cencora, and Laurie Fayzio, Head, Manufacturer Strategy, at FormularyDecisions. They explore the changing landscape of digital communication between biopharma companies and healthcare decision makers (HCDMs) and delve into 3 key topics that are crucial for effective engagement in the digital era with key decision makers: research on how HCDMs are utilizing digital resources and valuable insights into their preferences, how biopharma companies are adapting to meet the evolving needs of HCDMs in a post-pandemic peak era, and innovative strategies to optimize digital communications and the implications for stakeholder relationships.